Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines granted restricted stock unit awards covering an aggregate of 951 shares of common stock to five new non-executive employees. The grants were made by the Compensation Committee under the company's 2024 Inducement Plan as an inducement material to the employees entering into employment, pursuant to Nasdaq Listing Rule 5635(c)(4).
Key figures
- Number of recipients
- 5
- Inducement shares granted
- 951
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.